Bruker
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bruker and other ETFs, options, and stocks.About BRKR
Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST).
BRKR Key Statistics
BRKR News
Bruker Corporation (NASDAQ:BRKR) Q1 2024 Earnings Call Transcript May 2, 2024 Bruker Corporation misses on earnings expectations. Reported EPS is $0.3489 EPS,...
Bruker Corporation BRKR delivered adjusted earnings per share (EPS) of 53 cents in the first quarter of 2024, down 17.2% year over year. The figure topped the Z...
TD Cowen lowered the firm’s price target on Bruker to $80 from $91 and keeps a Hold rating on the shares. The firm said they saw progress on many fronts but not...
Analyst ratings
60%
of 10 ratingsMore BRKR News
Bruker (BRKR) reported $721.7 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 5.3%. EPS of $0.53 for the same per...
Q1 2024 Revenue: $721.7 million, an increase of 5.3% year-over-year, falling short beneath the estimated $729.88 million. Q1 2024 GAAP EPS: Reported at $0.35,...
Bruker (BRKR) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.64 p...
Bruker Corp (BRKR) has provided an announcement. Bruker Corporation has successfully completed its acquisition of ELITechGroup, a business previously known as...
Reports Q1 revenues of $721.7M,consensus 729.88M ; organic revenue up 1.6% yoy, and constant-exchange rate revenue up 5.5% yoy…Bruker’s President and CEO Frank...
Q1 2024 revenues of $721.7 million, up 5.3% year-over-year (yoy); organic revenue up 1.6% yoy, and constant-exchange rate (CER) revenue up 5.5% yoy Q1 2024 GAA...
Over the past year, many Bruker Corporation ( ) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insi...
